Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience)

Int J Dermatol. 2020 Oct;59(10):1287-1289. doi: 10.1111/ijd.15086. Epub 2020 Aug 9.

Authors

Giulia Pavia^{1

2}, Luigi Gargiulo^{1

2}, Mario Valenti^{1

2}, Paola Facheris^{1

2}, Ombretta Nucca^{1

3}, Alessandra Narcisi¹, Riccardo G Borroni^{1

2}, Antonio Costanzo^{1

2}

Affiliations

¹ Dermatology Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano (MI), Italy.
² Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Plastic Surgery Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano (MI), Italy.

No abstract available

Publication types

Letter

MeSH terms

Age Factors
Aged
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / transmission
COVID-19 / virology
Clinical Decision-Making / methods
Communicable Disease Control / organization & administration
Communicable Disease Control / standards
Dermatologic Surgical Procedures / standards*
Dermatology / organization & administration
Dermatology / standards
Disease Progression
Humans
Infectious Disease Transmission, Patient-to-Professional / prevention & control
Infectious Disease Transmission, Professional-to-Patient / prevention & control
Italy / epidemiology
Medical Oncology / organization & administration
Medical Oncology / standards
Pandemics / prevention & control
Patient Selection
Risk Assessment
SARS-CoV-2 / pathogenicity
Skin Neoplasms / pathology
Skin Neoplasms / surgery*
Time-to-Treatment*